Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M T Sandri

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Journal of Endocrinological Investigation|March 5, 2021
Vitamin D deficiency, secondary hyperparathyroidism and respiratory insufficiency in hospitalized patients with COVID-19G Mazziotti, E Lavezzi, A Brunetti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 3, 2005
Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer: antitumor activity and biological effectsM Colleoni, L Orlando, G Sanna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Effect of blood tamoxifen concentrations on surrogate biomarkers in a trial of dose reduction in healthy womenA Decensi, S Gandini, A Guerrieri-Gonzaga, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 7, 2007
Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implicationsF Nolé, E Munzone, L Zorzino, et al.
Critical Reviews in Oncology/Hematology|May 23, 2001
Timing of breast cancer surgery in relation to the menstrual cycle: an update of developmentsS Zurrida, V Galimberti, B Gibelli, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 6, 2001
Correlation between tamoxifen elimination and biomarker recovery in a primary prevention trialA Guerrieri-Gonzaga, L Baglietto, H Johansson, et al.
Ecancermedicalscience|January 26, 2012
The effect of transdermal estradiol or oral conjugated oestrogen and fenretinide versus placebo on haemostasis and cardiovascular risk biomarkers in a randomized breast cancer chemoprevention trialM Lazzeroni, D Macis, A Decensi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2002
Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levelsM Colleoni, A Rocca, M T Sandri, et al.
Breast Cancer Research and Treatment|November 9, 2011
Prognostic role of CA15.3 in 7942 patients with operable breast cancerM T Sandri, M Salvatici, E Botteri, et al.
European Journal of Ophthalmology|November 11, 2021
Conjunctivitis as a sign of persistent SARS-COV-2 infection? An observational study and report of late symptomsJose Luis Vallejo-Garcia, L Balia, R Raimondi, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Journal of Endocrinological Investigation|March 5, 2021
Vitamin D deficiency, secondary hyperparathyroidism and respiratory insufficiency in hospitalized patients with COVID-19G Mazziotti, E Lavezzi, A Brunetti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 3, 2005
Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer: antitumor activity and biological effectsM Colleoni, L Orlando, G Sanna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Effect of blood tamoxifen concentrations on surrogate biomarkers in a trial of dose reduction in healthy womenA Decensi, S Gandini, A Guerrieri-Gonzaga, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 7, 2007
Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implicationsF Nolé, E Munzone, L Zorzino, et al.
Critical Reviews in Oncology/Hematology|May 23, 2001
Timing of breast cancer surgery in relation to the menstrual cycle: an update of developmentsS Zurrida, V Galimberti, B Gibelli, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 6, 2001
Correlation between tamoxifen elimination and biomarker recovery in a primary prevention trialA Guerrieri-Gonzaga, L Baglietto, H Johansson, et al.
Ecancermedicalscience|January 26, 2012
The effect of transdermal estradiol or oral conjugated oestrogen and fenretinide versus placebo on haemostasis and cardiovascular risk biomarkers in a randomized breast cancer chemoprevention trialM Lazzeroni, D Macis, A Decensi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2002
Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levelsM Colleoni, A Rocca, M T Sandri, et al.
Breast Cancer Research and Treatment|November 9, 2011
Prognostic role of CA15.3 in 7942 patients with operable breast cancerM T Sandri, M Salvatici, E Botteri, et al.
European Journal of Ophthalmology|November 11, 2021
Conjunctivitis as a sign of persistent SARS-COV-2 infection? An observational study and report of late symptomsJose Luis Vallejo-Garcia, L Balia, R Raimondi, et al.
Pageof 4